Strategy
Page 1 • 2 itemsUnlock global pharma market insights. NovaPharmaNews delivers strategic intelligence for investors, BD, and analysts to drive pharmaceutical growth.
MHRA post-Brexit regulatory pathway vs EMA: Strategic Guide 2024
This strategic guide compares the MHRA and EMA regulatory pathways post-Brexit, focusing on drug approval processes for 2024.
EU Pharmaceutical Legislation Reform: Impact on Market Access & Innovation
The EU Pharmaceutical Legislation Reform aims to enhance market access and foster innovation, significantly affecting drug availability and patient care.